Jund is a determinant of macrophage activation and is associated with glomerulonephritis susceptibility.

PubWeight™: 1.31‹?› | Rank: Top 10%

🔗 View Article (PMC 2742200)

Published in Nat Genet on May 01, 2008

Authors

Jacques Behmoaras1, Gurjeet Bhangal, Jennifer Smith, Kylie McDonald, Brenda Mutch, Ping Chin Lai, Jan Domin, Laurence Game, Alan Salama, Brian M Foxwell, Charles D Pusey, H Terence Cook, Timothy J Aitman

Author Affiliations

1: Physiological Genomics and Medicine Group, Medical Research Council Clinical Sciences Centre, Imperial College, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK.

Articles citing this

Macrophages and immunologic inflammation of the kidney. Semin Nephrol (2010) 1.71

Polyamines regulate the stability of JunD mRNA by modulating the competitive binding of its 3' untranslated region to HuR and AUF1. Mol Cell Biol (2010) 1.17

IL-10 inhibits transcription elongation of the human TNF gene in primary macrophages. J Exp Med (2010) 1.07

Genetics of hypertension: from experimental animals to humans. Biochim Biophys Acta (2009) 1.00

Genetic loci modulate macrophage activity and glomerular damage in experimental glomerulonephritis. J Am Soc Nephrol (2010) 0.99

Pigment epithelium-derived factor is an intrinsic antifibrosis factor targeting hepatic stellate cells. Am J Pathol (2010) 0.98

Non-thermal plasma activates human keratinocytes by stimulation of antioxidant and phase II pathways. J Biol Chem (2015) 0.95

A susceptibility gene for kidney disease in an obese mouse model of type II diabetes maps to chromosome 8. Kidney Int (2010) 0.92

Identification of a novel gene for diabetic traits in rats, mice, and humans. Genetics (2014) 0.89

Alternative splicing and transcriptome profiling of experimental autoimmune encephalomyelitis using genome-wide exon arrays. PLoS One (2009) 0.88

Strain differences and the genetic basis of experimental autoimmune anti-glomerular basement membrane glomerulonephritis. Int J Exp Pathol (2011) 0.88

Genetic susceptibility and loss of Nr4a1 enhances macrophage-mediated renal injury in CKD. J Am Soc Nephrol (2014) 0.86

Mannose receptor interacts with Fc receptors and is critical for the development of crescentic glomerulonephritis in mice. J Clin Invest (2010) 0.85

Combined ChIP-Seq and transcriptome analysis identifies AP-1/JunD as a primary regulator of oxidative stress and IL-1β synthesis in macrophages. BMC Genomics (2013) 0.84

Characterization of the macrophage transcriptome in glomerulonephritis-susceptible and -resistant rat strains. Genes Immun (2010) 0.83

Kcnn4 is a regulator of macrophage multinucleation in bone homeostasis and inflammatory disease. Cell Rep (2014) 0.83

Genetic susceptibility to experimental autoimmune glomerulonephritis in the Wistar Kyoto rat. Am J Pathol (2012) 0.83

JunD enhances miR-29b levels transcriptionally and posttranscriptionally to inhibit proliferation of intestinal epithelial cells. Am J Physiol Cell Physiol (2015) 0.81

Autoimmunity to the alpha 3 chain of type IV collagen in glomerulonephritis is triggered by 'autoantigen complementarity'. J Autoimmun (2015) 0.81

Combined protein- and nucleic acid-level effects of rs1143679 (R77H), a lupus-predisposing variant within ITGAM. Hum Mol Genet (2014) 0.81

Hypertensive renal injury is associated with gene variation affecting immune signaling. Circ Cardiovasc Genet (2014) 0.80

AP-1 transcription factor JunD confers protection from accelerated nephrotoxic nephritis and control podocyte-specific Vegfa expression. Am J Pathol (2011) 0.80

Integrating phosphoproteome and transcriptome reveals new determinants of macrophage multinucleation. Mol Cell Proteomics (2014) 0.80

Role of novel rat-specific Fc receptor in macrophage activation associated with crescentic glomerulonephritis. J Biol Chem (2011) 0.80

Experimental crescentic glomerulonephritis: a new bicongenic rat model. Dis Model Mech (2013) 0.80

Comparison of small interfering RNA (siRNA) delivery into bovine monocyte-derived macrophages by transfection and electroporation. Vet Immunol Immunopathol (2014) 0.80

Macrophage epoxygenase determines a profibrotic transcriptome signature. J Immunol (2015) 0.79

From integrative genomics to systems genetics in the rat to link genotypes to phenotypes. Dis Model Mech (2016) 0.79

Identification of a nutrient-sensing transcriptional network in monocytes by using inbred rat models on a cafeteria diet. Dis Model Mech (2016) 0.78

Combining genetic mapping with genome-wide expression in experimental autoimmune encephalomyelitis highlights a gene network enriched for T cell functions and candidate genes regulating autoimmunity. Hum Mol Genet (2013) 0.77

JunD/AP1 regulatory network analysis during macrophage activation in a rat model of crescentic glomerulonephritis. BMC Syst Biol (2013) 0.76

A Bayesian Approach for Analysis of Whole-Genome Bisulfite Sequencing Data Identifies Disease-Associated Changes in DNA Methylation. Genetics (2017) 0.75

New Wistar Kyoto and spontaneously hypertensive rat transgenic models with ubiquitous expression of green fluorescent protein. Dis Model Mech (2016) 0.75

Unique regulatory properties of mesangial cells are genetically determined in the rat. PLoS One (2014) 0.75

Transcriptional regulation of importin-α1 by JunD modulates subcellular localization of RNA-binding protein HuR in intestinal epithelial cells. Am J Physiol Cell Physiol (2016) 0.75

BCAT1 controls metabolic reprogramming in activated human macrophages and is associated with inflammatory diseases. Nat Commun (2017) 0.75

Articles cited by this

Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature (2006) 9.30

Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet (1999) 4.48

JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell (2004) 3.30

Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int (2007) 3.09

Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol (2004) 2.58

Conditional ablation of macrophages halts progression of crescentic glomerulonephritis. Am J Pathol (2005) 2.38

Involvement of the Arp2/3 complex in phagocytosis mediated by FcgammaR or CR3. Nat Cell Biol (2000) 2.29

Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell (1994) 2.00

JunD protects cells from p53-dependent senescence and apoptosis. Mol Cell (2000) 1.99

Evidence for a pathogenic role of a cell-mediated immune mechanism in experimental glomerulonephritis. J Exp Med (1978) 1.98

Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat Genet (2001) 1.26

Development of scarring and renal failure in a rat model of crescentic glomerulonephritis. Nephrol Dial Transplant (1999) 1.14

Functional characteristics of macrophages in glomerulonephritis in the rat. O2- generation, MHC class II expression, and eicosanoid synthesis. Am J Pathol (1989) 1.11

Genes expressed by both mesangial cells and bone marrow-derived cells underlie genetic susceptibility to crescentic glomerulonephritis in the rat. J Am Soc Nephrol (2007) 1.07

JunD regulates lymphocyte proliferation and T helper cell cytokine expression. EMBO J (2004) 1.04

Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats. Nephrol Dial Transplant (2004) 1.03

Differential macrophage expression of IL-12 and IL-23 upon innate immune activation defines rat autoimmune susceptibility. J Leukoc Biol (2004) 1.03

Macrophages in acute glomerular inflammation. Kidney Int (1994) 1.01

Interleukin-11 attenuates nephrotoxic nephritis in Wistar Kyoto rats. J Am Soc Nephrol (2001) 0.95

Pro-resolution properties of macrophages in renal injury. Kidney Int (2007) 0.94

Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats. Kidney Int (1999) 0.94

A pathogenic role for JNK signaling in experimental anti-GBM glomerulonephritis. Kidney Int (2007) 0.92

Suppression of NF-kappa B and AP-1 activation by glucocorticoids in experimental glomerulonephritis in rats: molecular mechanisms of anti-nephritic action. Biochim Biophys Acta (1997) 0.92

Macrophage-mediated renal injury is dependent on signaling via the JNK pathway. J Am Soc Nephrol (2004) 0.89

c-Jun N-terminal kinase-mediated AP-1 activation in experimental glomerulonephritis in rats. Biochem Mol Biol Int (1998) 0.82

Articles by these authors

Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature (2006) 9.30

Repeatability of published microarray gene expression analyses. Nat Genet (2008) 8.24

Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat Genet (2005) 7.82

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int (2009) 7.45

Finding genes that underlie complex traits. Science (2002) 7.39

The MGED Ontology: a resource for semantics-based description of microarray experiments. Bioinformatics (2006) 7.37

The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int (2009) 7.19

Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med (2012) 6.93

One-third of reef-building corals face elevated extinction risk from climate change and local impacts. Science (2008) 6.68

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med (2009) 6.61

Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol (2007) 6.13

FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet (2007) 5.93

Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet (2002) 4.22

The Rat Genome Database 2009: variation, ontologies and pathways. Nucleic Acids Res (2008) 3.92

Genetic loci influencing kidney function and chronic kidney disease. Nat Genet (2010) 3.75

Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet (2010) 3.74

Pathologic classification of diabetic nephropathy. J Am Soc Nephrol (2010) 3.61

Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol (2005) 3.57

Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol (2010) 3.48

Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids. Ann Rheum Dis (2013) 3.39

C3 glomerulopathy: a new classification. Nat Rev Nephrol (2010) 3.17

New approaches to the treatment of dense deposit disease. J Am Soc Nephrol (2007) 3.02

A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature (2010) 2.88

C3 glomerulopathy: consensus report. Kidney Int (2013) 2.85

Heritability and tissue specificity of expression quantitative trait loci. PLoS Genet (2006) 2.80

Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol (2003) 2.69

Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains. J Exp Med (2007) 2.55

Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort. Nephrol Dial Transplant (2011) 2.51

Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal. Cell (2013) 2.49

The inhibiting Fc receptor for IgG, FcγRIIB, is a modifier of autoimmune susceptibility. J Immunol (2011) 2.44

New insights into the genetic control of gene expression using a Bayesian multi-tissue approach. PLoS Comput Biol (2010) 2.43

Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis (2003) 2.40

Cytoscape: a community-based framework for network modeling. Methods Mol Biol (2009) 2.39

The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int (2010) 2.14

Hyperspectral and physiological analyses of coral-algal interactions. PLoS One (2009) 2.07

Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol (2003) 2.03

Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis. Nephrol Dial Transplant (2011) 2.03

Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice. J Clin Invest (2008) 1.94

Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells (2006) 1.90

The development of atypical hemolytic uremic syndrome depends on complement C5. J Am Soc Nephrol (2010) 1.88

C1q deficiency and autoimmunity: the effects of genetic background on disease expression. J Immunol (2002) 1.88

Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood (2005) 1.86

Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int (2004) 1.85

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology (Oxford) (2011) 1.79

Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men. Gut (2010) 1.77

The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant (2004) 1.73

Modified dendritic cells coexpressing self and allogeneic major histocompatability complex molecules: an efficient way to induce indirect pathway regulation. J Am Soc Nephrol (2004) 1.72

Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol (2004) 1.68

Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J Am Soc Nephrol (2008) 1.68

Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP. Blood (2003) 1.67

Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nat Genet (2008) 1.67

Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees. Clin J Am Soc Nephrol (2011) 1.66

Interferon-beta reduces proteinuria in experimental glomerulonephritis. J Am Soc Nephrol (2007) 1.63

Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis. Arthritis Rheum (2009) 1.59

Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems. Blood (2007) 1.57

MiMiR: a comprehensive solution for storage, annotation and exchange of microarray data. BMC Bioinformatics (2005) 1.54

CD59a deficiency exacerbates accelerated nephrotoxic nephritis in mice. J Am Soc Nephrol (2003) 1.54

Genome sequencing reveals loci under artificial selection that underlie disease phenotypes in the laboratory rat. Cell (2013) 1.53

Health promotion for adolescent childhood leukemia survivors: building on prevention science and ehealth. Pediatr Blood Cancer (2012) 1.52

Elevated soluble Flt1 inhibits endothelial repair in PR3-ANCA-associated vasculitis. J Am Soc Nephrol (2011) 1.50

ABO incompatible living renal transplantation with a steroid sparing protocol. Transplantation (2008) 1.48

The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis. Am J Pathol (2007) 1.47

Effect of L-carnitine administration on erythrocyte survival in haemodialysis patients. Nephrol Dial Transplant (2006) 1.46

Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrol Dial Transplant (2010) 1.46

Bone marrow-derived cells do not contribute significantly to collagen I synthesis in a murine model of renal fibrosis. J Am Soc Nephrol (2006) 1.46

The genome sequence of the spontaneously hypertensive rat: Analysis and functional significance. Genome Res (2010) 1.45

A medical outreach elective course. Am J Pharm Educ (2013) 1.44

A unique Mycobacterium ESX-1 protein co-secretes with CFP-10/ESAT-6 and is necessary for inhibiting phagosome maturation. Mol Microbiol (2007) 1.44

The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol (2009) 1.43

Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Am J Kidney Dis (2002) 1.42

Proliferation of bone marrow-derived cells contributes to regeneration after folic acid-induced acute tubular injury. J Am Soc Nephrol (2005) 1.41

Drug insight: rituximab in renal disease and transplantation. Nat Clin Pract Nephrol (2006) 1.41

Non-hepatitis virus associated mixed essential cryoglobulinemia. Kidney Int (2009) 1.40

Systematic biases in DNA copy number originate from isolation procedures. Genome Biol (2013) 1.39

EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis (2010) 1.38

Surgical pearl: cups for caps--monitoring doses of local anesthesia. J Am Acad Dermatol (2006) 1.38

Genetic analysis of autoimmune type 1 diabetes mellitus in mice. 1991. J Immunol (2014) 1.37

Genetic dissection of spontaneous autoimmunity driven by 129-derived chromosome 1 Loci when expressed on C57BL/6 mice. J Immunol (2007) 1.34

eQTL Explorer: integrated mining of combined genetic linkage and expression experiments. Bioinformatics (2005) 1.31

Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy. Blood (2004) 1.30

Infrared micro-spectral imaging: distinction of tissue types in axillary lymph node histology. BMC Clin Pathol (2008) 1.26

Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice. Kidney Int (2010) 1.25

Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition. Kidney Int (2011) 1.24

Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy. Cytokine (2009) 1.23